Biomx Inc (PHGE)

Currency in USD
1.930
-0.280(-12.67%)
Closed·
1.900-0.030(-1.55%)
·
PHGE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8802.220
52 wk Range
1.50014.712
Key Statistics
Prev. Close
2.21
Open
2.22
Day's Range
1.88-2.22
52 wk Range
1.5-14.712
Volume
217.82K
Average Vol. (3m)
1.04M
1-Year Change
-81.7304%
Book Value / Share
-13.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHGE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
304.000
Upside
+15,651.29%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Biomx Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company’s phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.

Compare PHGE to Peers and Sector

Metrics to compare
PHGE
Peers
Sector
Relationship
P/E Ratio
−0.1x−3.3x−0.5x
PEG Ratio
0.00−0.010.00
Price / Book
−0.2x1.2x2.6x
Price / LTM Sales
-656.8x3.2x
Upside (Analyst Target)
-792.9%47.6%
Fair Value Upside
Unlock−8.1%6.1%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 304.000
(+15,651.29% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold---DowngradeMar 09, 2026
H.C. Wainwright
Buy26.00+1,247.15%-MaintainNov 28, 2025
H.C. Wainwright
Buy15.00+677.20%-MaintainAug 20, 2025
H.C. Wainwright
Buy15.00+677.20%-MaintainJul 15, 2025
H.C. Wainwright
Buy15.00+677.20%-MaintainJul 15, 2025

Earnings

Latest Release
Feb 19, 2026
EPS / Forecast
-6.67 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PHGE Income Statement

People Also Watch

40.96
SWMR
-3.21%
2.0300
ZCMD
+4.10%
0.5351
ENSC
+2.90%
3.30
BATL
-1.49%
7.78
IBRX
+2.37%

FAQ

What Is the Biomx (PHGE) Stock Price Today?

The Biomx stock price today is 1.930 USD.

What Stock Exchange Does Biomx Trade On?

Biomx is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Biomx?

The stock symbol for Biomx is "PHGE."

What Is the Biomx Market Cap?

As of today, Biomx market cap is 3.520M USD.

What Is Biomx's Earnings Per Share (TTM)?

The Biomx EPS (TTM) is -22.194.

From a Technical Analysis Perspective, Is PHGE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biomx Stock Split?

Biomx has split 2 times.

How Many Employees Does Biomx Have?

Biomx has 20 employees.

What is the current trading status of Biomx (PHGE)?

As of Apr 15, 2026, Biomx (PHGE) is trading at a price of 1.930 USD, with a previous close of 2.210 USD. The stock has fluctuated within a day range of 1.880 USD to 2.220 USD, while its 52-week range spans from 1.500 USD to 14.712 USD.

What Is Biomx (PHGE) Price Target According to Analysts?

The average 12-month price target for Biomx is 304.000 USD, with a high estimate of 303.99999 USD and a low estimate of 303.99999 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +15,651.29% Upside potential.

What Is the PHGE Premarket Price?

PHGE's last pre-market stock price is 2.220 USD. The pre-market share volume is 2,750.000, and the stock has decreased by 0.010, or 0.450%.

What Is the PHGE After Hours Price?

PHGE's last after hours stock price is 1.900 USD, the stock has decreased by -0.030, or -1.550%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.